MétaCan
Menu
Back to cohort
Record W1963678166 · doi:10.1111/all.12437

Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology

2014· article· en· W1963678166 on OpenAlexaff
Antonella Muraro, Graham Roberts, Margitta Worm, Maria Beatrice Bilò, Knut Brockow, Montserrat Fernández‐Rivas, Alexandra F. Santos, Zaraquiza Zolkipli, Abdelouahab Bellou, Kirsten Beyer, Carsten Bindslev‐Jensen, Victória Cardona, Andrew Clark, Pascal Demoly, A. E. J. Dubois, Audrey DunnGalvin, Philippe Eigenmann, Susanne Halken, L. Harada, Gideon Lack, Marek Jutel, B. Niggemann, Franziska Ruëff, Frans Timmermans, Berber Vlieg‐Boerstra, Thomas Werfel, Sangeeta Dhami, Sukhmeet S. Panesar, Cezmi A. Akdiş, Aziz Sheikh

Bibliographic record

VenueAllergy · 2014
Typearticle
Languageen
FieldMedicine
TopicFood Allergy and Anaphylaxis Research
Canadian institutionsPyrogenesis (Canada)
FundersEuropean Academy of Allergy and Clinical ImmunologyLes Laboratories Pierre FabreMead Johnson NutritionAllergopharmaWorld Health OrganizationDanoneSanofiPfizer
KeywordsMedicineAnaphylaxisIntensive care medicineAllergyClinical immunologyPsychological interventionMedical emergencyGuidelineImmunologyNursingPathology

Abstract

fetched live from OpenAlex

Anaphylaxis is a clinical emergency, and all healthcare professionals should be familiar with its recognition and acute and ongoing management. These guidelines have been prepared by the European Academy of Allergy and Clinical Immunology (EAACI) Taskforce on Anaphylaxis. They aim to provide evidence-based recommendations for the recognition, risk factor assessment, and the management of patients who are at risk of, are experiencing, or have experienced anaphylaxis. While the primary audience is allergists, these guidelines are also relevant to all other healthcare professionals. The development of these guidelines has been underpinned by two systematic reviews of the literature, both on the epidemiology and on clinical management of anaphylaxis. Anaphylaxis is a potentially life-threatening condition whose clinical diagnosis is based on recognition of a constellation of presenting features. First-line treatment for anaphylaxis is intramuscular adrenaline. Useful second-line interventions may include removing the trigger where possible, calling for help, correct positioning of the patient, high-flow oxygen, intravenous fluids, inhaled short-acting bronchodilators, and nebulized adrenaline. Discharge arrangements should involve an assessment of the risk of further reactions, a management plan with an anaphylaxis emergency action plan, and, where appropriate, prescribing an adrenaline auto-injector. If an adrenaline auto-injector is prescribed, education on when and how to use the device should be provided. Specialist follow-up is essential to investigate possible triggers, to perform a comprehensive risk assessment, and to prevent future episodes by developing personalized risk reduction strategies including, where possible, commencing allergen immunotherapy. Training for the patient and all caregivers is essential. There are still many gaps in the evidence base for anaphylaxis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.031
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.013
Threshold uncertainty score0.050

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.031
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0030.004
Bibliometrics0.0070.005
Science and technology studies0.0010.001
Scholarly communication0.0040.003
Open science0.0040.003
Research integrity0.0080.010
Insufficient payload (model declined to judge)0.0130.017

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.068
GPT teacher head0.368
Teacher spread0.300 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1,049
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueAllergySame topicFood Allergy and Anaphylaxis ResearchFrench-language works237,207